quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:06:15·2d
SECFiling
Neuropace Inc. logo

SEC Form DEFA14A filed by Neuropace Inc.

NPCE· Neuropace Inc.
Health Care
Original source

Companies

  • NPCE
    Neuropace Inc.
    Health Care

Recent analyst ratings

  • May 28UpdateH.C. Wainwright$18.00
  • Jan 21UpdateUBS$17.00
  • Mar 14UpdateWells Fargo$20.00
  • Jan 30UpdateLeerink Partners$22.00
  • Nov 10UpdateCantor Fitzgerald$11.00
  • Aug 24UpdateMorgan Stanley$6.00

Related

  • SEC2d
    SEC Form DEF 14A filed by Neuropace Inc.
  • PR13d
    NeuroPace to Present at the 25th Annual Needham Virtual Healthcare Conference
  • INSIDER29d
    SEC Form 4 filed by Morrell Martha
  • INSIDER30d
    SEC Form 4 filed by Geiger Uri
  • INSIDER30d
    SEC Form 4 filed by Lacob Joseph
  • INSIDER31d
    SEC Form 4 filed by Kumar Rakhi
  • INSIDER31d
    SEC Form 4 filed by Fischer Frank M
  • PR49d
    NeuroPace to Present at the Leerink Global Healthcare Conference
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022